Ticker
PROKCompany Name
PROKIDNEY CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ -1B | $ -72.47M | 0% |
3/31/2025 | $ -998.55M | $ -68.43M | 0% |
12/31/2024 | $ -994.95M | $ -61.19M | 0% |
9/30/2024 | $ -979.71M | $ -45.61M | 0% |
6/30/2024 | $ -972.37M | $ -38.68M | 0% |
3/31/2024 | $ -1.1B | $ -35.3M | 0% |
12/31/2023 | $ -1.1B | $ -35.47M | 0% |
9/30/2023 | $ -1.09B | $ -36.25M | 0% |
6/30/2023 | $ -1.32B | $ -37.2M | 0% |
3/31/2023 | $ -1.6B | $ -30.35M | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for PROKIDNEY CORP is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 19.82K ]
(=) ROE [ 0% ]
Minimum
Jun 30, 2022
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.14K |
---|---|
min | -66.79% |
max | 73.25% |
average | 1.51% |
median | 6.45% |
std | 22.68% |